Comparative activities of ampicillin and teicoplanin against Enterococcus faecalis isolates
- PMID: 36609223
- PMCID: PMC9817409
- DOI: 10.1186/s12866-022-02753-1
Comparative activities of ampicillin and teicoplanin against Enterococcus faecalis isolates
Abstract
Background: Enterococcus faecalis remains one of the most common pathogens causing infection in surgical patients. Our goal was to evaluate the antibiotic resistance of E. faecalis, causing infections in a surgical clinic, against two antibacterial drugs, ampicillin and teicoplanin. One commonly administered in the past for such infections, ampicillin, and another newer, teicoplanin, which demonstrated exceptionally good efficacy.
Methods: Data from 1882 isolates were retrieved from the microbiology department database during two 5-year periods. Standard biochemical methods were employed for the identification of the isolates. The prevalence of E. faecalis among patients with clinical evidence of infection in a surgical oncology ward was assessed. Confidence interval (CI) as well as standard error (SE) were calculated. Moreover, the annual incidence of E. faecalis infections in this surgical ward was recorded. The susceptibility of E. faecalis to ampicillin and teicoplanin was studied and compared using Fisher's exact test.
Results and conclusion: Results showed that the incidence of E. faecalis infections in the surgical clinic was increasing. Ampicillin, in the later year period, was not statistically different from teicoplanin in treating E. faecalis infections. Consequently, ampicillin seems currently to be an effective antibiotic against such infections that could be used as empiric therapy.
Keywords: Ampicillin; Antibiotic resistance; Enterococcus faecalis; Teicoplanin.
© 2023. The Author(s).
Conflict of interest statement
All authors declare no competing interests.
Figures






Similar articles
-
Resistance of enterococci to ampicillin and glycopeptide antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance.Clin Infect Dis. 1998 Aug;27 Suppl 1:S84-6. doi: 10.1086/514907. Clin Infect Dis. 1998. PMID: 9710675
-
Antibiotic susceptibility of periodontal Enterococcus faecalis.J Periodontol. 2013 Jul;84(7):1026-33. doi: 10.1902/jop.2012.120050. Epub 2012 Oct 29. J Periodontol. 2013. PMID: 23106507
-
Enterococcus faecalis: in vitro activity of antimicrobial drugs, singly and combined, with and without defibrinated human blood, against high-level-gentamicin-resistant isolates.Chemotherapy. 1993 Jul-Aug;39(4):248-53. doi: 10.1159/000239133. Chemotherapy. 1993. PMID: 8325126
-
In vitro efficacy of fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus isolates.Diagn Microbiol Infect Dis. 2013 Nov;77(3):254-7. doi: 10.1016/j.diagmicrobio.2013.07.012. Epub 2013 Sep 9. Diagn Microbiol Infect Dis. 2013. PMID: 24029433
-
Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.Acta Microbiol Immunol Hung. 2011 Sep;58(3):219-26. doi: 10.1556/AMicr.58.2011.3.5. Acta Microbiol Immunol Hung. 2011. PMID: 21983323
Cited by
-
Impacts of host phylogeny, diet, and geography on the gut microbiome of rodents.PLoS One. 2025 Jan 16;20(1):e0316101. doi: 10.1371/journal.pone.0316101. eCollection 2025. PLoS One. 2025. PMID: 39820176 Free PMC article.
-
Functional genomics of antibiotic susceptibility in Enterococcus faecalis from infective endocarditis.J Infect Dis. 2025 May 30:jiaf272. doi: 10.1093/infdis/jiaf272. Online ahead of print. J Infect Dis. 2025. PMID: 40444324 Free PMC article.
-
Exploring Plant-Based Compounds as Alternatives for Targeting Enterococcus faecalis in Endodontic Therapy: A Molecular Docking Approach.Int J Mol Sci. 2024 Jul 15;25(14):7727. doi: 10.3390/ijms25147727. Int J Mol Sci. 2024. PMID: 39062969 Free PMC article.
-
Antimicrobial Susceptibility Profiles of Commensal Enterococcus spp. Isolates from Turkeys in Hungarian Poultry Farms Between 2022 and 2023.Antibiotics (Basel). 2025 Mar 21;14(4):331. doi: 10.3390/antibiotics14040331. Antibiotics (Basel). 2025. PMID: 40298473 Free PMC article.
-
Outcomes of Enterococcus faecalis infective endocarditis according to MIC of amoxicillin: a multicentric study.JAC Antimicrob Resist. 2024 Nov 1;6(6):dlae167. doi: 10.1093/jacamr/dlae167. eCollection 2024 Dec. JAC Antimicrob Resist. 2024. PMID: 39493937 Free PMC article.
References
-
- Ator LL, Starzyk MJ. Distribution of group D streptococci in rivers and streams. Microbios. 1976;16:91–104. - PubMed
-
- Mundt JO. Bergey痴 manual of systematic bacteriology. Baltimore: Williams & Wilkins; 1986. Enterococci; pp. 1063–1065.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous